Perspectives on immunization

Journal of Managed Care Medicine

Volumn 15, Issue 3, 2012, Pages 5-10

  Marshall, Gary S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MENHIBRIX; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ADVERSE OUTCOME; ARTICLE; BRAIN DISEASE; CHICKENPOX; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEHYDRATION; DIARRHEA; DRUG EFFECT; DRUG SAFETY; HAEMOPHILUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOREACTIVITY; INFECTION PREVENTION; INFLUENZA; INTESTINE OBSTRUCTION; INTUSSUSCEPTION; MEASLES; MENINGOCOCCOSIS; MUMPS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; RUBELLA; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VACCINE PRODUCTION;

EID: 84868678569     PISSN: 10941525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CDC. Progress Toward Elimination of Haemophilus influenzae Type b Invasive Disease among infants and children, United States, 1998-2000. MMWR. Vol 51, No 11;234.
2. Offit PA, Quarles J, Gerber MA, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109(1):124-9.
3. Marshall GS. The Vaccine Handbook: A Practical Guide for Clinicians. 3rd Edition. West Islip, NY: PCI Books. 2010.
4. Marshall GS. One for all: newer combination vaccines in practice. Pediatr Ann. 2004;33(8):501-11.
5. Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496-500.
6. Happe LE, Lunacsek OE, Kruzikas DT, Marshall GS. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population. Pediatr Infect Dis J. 2009;28(2):98-101.
7. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13(1):28-41.
8. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359(8):821-32.
9. McNabb SJ, Jajosky RA, Hall-Baker PA, et al. Summary of notifiable diseases-United States, 2006. MM WR Morb Mortal Wkly Rep. 2008;55(53):1-92.
10. Roush SW, Murphy TV.; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-63.
11. Zhou F, Santoli J, Messonnier ML, Yusuf HR, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med. 2005;159(12):1136-44.
12. CDC. National and state vaccination coverage among children aged 19-35 months--United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(34):1157-63.
13. CDC. National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MM WR Morb Mortal Wkly Rep. 2011;60(33):1117-23.
14. Leask J. Target the fence-sitters. Nature. 2011;473(7348):443-5.
15. Kennedy A, Basket M, Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics. 2011;127 Suppl 1:S92-9.